These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27664108)

  • 1. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
    Beby AT; Cornelis T; Zinck R; Liu FX
    Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective.
    Liu FX; Treharne C; Arici M; Crowe L; Culleton B
    Value Health; 2015 Jan; 18(1):17-24. PubMed ID: 25595230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
    Liu FX; Treharne C; Culleton B; Crowe L; Arici M
    BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options.
    Gonzalez-Perez JG; Vale L; Stearns SC; Wordsworth S
    Int J Technol Assess Health Care; 2005; 21(1):32-9. PubMed ID: 15736512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An operating cost comparison between conventional and home quotidian hemodialysis.
    Kroeker A; Clark WF; Heidenheim AP; Kuenzig L; Leitch R; Meyette M; Muirhead N; Ryan H; Welch R; White S; Lindsay RM
    Am J Kidney Dis; 2003 Jul; 42(1 Suppl):49-55. PubMed ID: 12830444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-five years of experience with out-center hemodialysis.
    Arkouche W; Traeger J; Delawari E; Sibaï-Galland R; Abdullah E; Galland R; Leitienne P; Fouque D; Laville M
    Kidney Int; 1999 Dec; 56(6):2269-75. PubMed ID: 10594805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis.
    Surendra NK; Abdul Manaf MR; Hooi LS; Bavanandan S; Mohamad Nor FS; Firdaus Khan SS; Meng OL; Abdul Gafor AH
    PLoS One; 2019; 14(10):e0218422. PubMed ID: 31644577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.
    McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
    Kidney Int; 2003 Sep; 64(3):1004-11. PubMed ID: 12911550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cost Effectiveness of High-Dose versus Conventional Haemodialysis: a Systematic Review.
    Laplante S; Liu FX; Culleton B; Bernardo A; King D; Hudson P
    Appl Health Econ Health Policy; 2016 Apr; 14(2):185-93. PubMed ID: 26691659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study.
    Lévesque R; Marcelli D; Cardinal H; Caron ML; Grooteman MP; Bots ML; Blankestijn PJ; Nubé MJ; Grassmann A; Canaud B; Gandjour A
    Appl Health Econ Health Policy; 2015 Dec; 13(6):647-59. PubMed ID: 26071951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis.
    McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
    Kidney Int; 2006 Mar; 69(5):798-805. PubMed ID: 16407887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.
    Vegter S; Tolley K; Keith MS; Lok CE; Soroka SD; Morton AR
    Clin Ther; 2012 Jul; 34(7):1531-43. PubMed ID: 22742885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation vs hemodialysis: cost-effectiveness analysis.
    Perović S; Janković S
    Vojnosanit Pregl; 2009 Aug; 66(8):639-44. PubMed ID: 19780419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The marginal cost of satellite versus in-center hemodialysis.
    Soroka SD; Kiberd BA; Jacobs P
    Hemodial Int; 2005 Apr; 9(2):196-201. PubMed ID: 16191069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.